A Phase II Study of continuous, low-dose LBH 589 (Panobinostat) in Patients with Refractory Solid Tumors, including CNS tumors

  • Desai, Jayesh R. (Primary Chief Investigator (PCI))
  • Ashley, David M. (Chief Investigator (CI))
  • Cain, Jason (Chief Investigator (CI))
  • Gottardo, Nicholas G. (Chief Investigator (CI))
  • Wood, Paul (Chief Investigator (CI))
  • Strong, Robyn (Project Manager)

Project: Research

Project Details

Effective start/end date1/07/1731/12/22


  • Kids' Cancer Project: A$61,420.00
  • National Health and Medical Research Council (NHMRC) (Australia): A$811,512.00